Completed PHASE3 INTERVENTIONAL NCT00265031

HD12 for Advanced Stages

Sponsor: University of Cologne

Interventions Adriamycin Bleomycin Cyclophosphamide Etoposide Prednisone Procarbazine Vincristine radiation therapy

Updated 5 times since 2017 Last updated: Jun 22, 2012 Started: Jan 31, 1999

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT00265031, this PHASE3 trial focuses on Hodgkin´s Lymphoma and remains completed. Sponsored by University of Cologne, it has been updated 5 times since 1999, reflecting limited change activity. This study contributes to the evolving evidence base for cancer treatment protocols.

Status Flow

Change History

5 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE3
Jul 2024 — Sep 2024 [monthly]

Completed PHASE3
Jan 2021 — Jul 2024 [monthly]

Completed PHASE3
Jun 2018 — Jan 2021 [monthly]

Completed PHASE3
Jan 2017 — Jun 2018 [monthly]

Completed PHASE3

First recorded

Jan 1999

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

University of Cologne

Data source: University of Cologne

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

No location information available.